TrialAnnals of the rheumatic diseases2016

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).

Yuko Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.